CardioComm Solutions Inc (EKG):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:CardioComm Solutions Inc (EKG) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6592
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:34
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
CardioComm Solutions Inc (CardioComm) is a medical technology company that offers software solutions for information management systems in cardiovascular medicine and telemedicine. The company offers software engineering of computer based electrocardiogram management and reporting software. Its products include software, hardware, software modules and other products. CardioComm provides ECG management services and enterprise solutions. The company also offers PC and LAN based products, internet based SAAS and ASP software, a medical ECG service, arrhythmia monitoring ECG protocols and supports traditional transtelephonic transmissions through wireless communication. The company caters to medical diagnostic and consumer market industries. It markets its products in Canada and the US. CardioComm is headquartered in North York, Ontario, Canada.

CardioComm Solutions Inc (EKG) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
CardioComm Solutions Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
CardioComm Solutions Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
CardioComm Solutions Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
CardioComm Solutions Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
CardioComm Solutions Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
CardioComm Solutions Inc, Medical Equipment, Deal Details 10
Partnerships 10
Biotricity Enters into Licensing Agreement with CardioComm Solutions 10
CardioComm Solutions Enters into Partnership with Visiomed Group 11
CardioComm Solutions and Vigilance Form Joint Venture 12
CardioComm Solutions Enters Into Co-Development Agreement With Monebo Technologies For ECG Interpretation Software 13
CardioComm Solutions Enters Into Technology Integration Agreement With Royal Philips Electronics 15
CardioComm Solutions Enters Into Technology Integration Agreement With TZ Medical 16
CardioComm Solutions Enters Into Distribution Agreement With TZ Medical 17
Equity Offering 18
CardioComm Solutions Completes First Tranche Of Private Placement For US$0.1 Millon 18
CardioComm Solutions Completes Private Placement Of Units For US$0.12 Million 19
CardioComm Solutions Completes Private Placement Of Units For US$1.55 Million 20
CardioComm Solutions Completes Private Placement Of Common Stock For US$1 Million Upon Exercise Of Warrants 22
CardioComm Solutions Inc – Key Competitors 23
CardioComm Solutions Inc – Key Employees 24
CardioComm Solutions Inc – Locations And Subsidiaries 25
Head Office 25
Other Locations & Subsidiaries 25
Recent Developments 26
Financial Announcements 26
Apr 30, 2018: Cardiocomm solutions reports a profitable fy2017 and revenue growth 26
May 31, 2017: CardioComm Solutions Reports a Profitable Start to 2017 and Net Positive Cash Flow over the Last Four Fiscal Quarters 27
May 02, 2017: 2016 Year End Financials Confirm Cardiocomm Solutions Is at an Inflection Point as a Recognized Medical Solutions Provider 28
Corporate Communications 29
Nov 23, 2017: CardioComm Solutions Announces Addition of Banking Veteran to Its Board of Directors 29
Oct 25, 2017: Cardiocomm Solutions Annouces Updates To Its Board Of Directors 30
Product News 31
Dec 18, 2017: Cardiocomm Solutions Releases Gems Home Flex Software for Apple’s Mac and Windows’ Computer Operating Systems 31
Other Significant Developments 32
Feb 22, 2018: Cardiocomm Solutions Participates in Ontario Trade Mission to Japan and Korea 32
Apr 24, 2017: Carespan to Integrate Cardiocomm Solutions’ Electrocardiogram Toolset Into Its Virtual Clinic 33
Appendix 34
Methodology 34
About GlobalData 34
Contact Us 34
Disclaimer 34

List of Tables
CardioComm Solutions Inc, Medical Equipment, Key Facts, 2017 2
CardioComm Solutions Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
CardioComm Solutions Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
CardioComm Solutions Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
CardioComm Solutions Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
CardioComm Solutions Inc, Deals By Market, 2012 to YTD 2018 8
CardioComm Solutions Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Biotricity Enters into Licensing Agreement with CardioComm Solutions 10
CardioComm Solutions Enters into Partnership with Visiomed Group 11
CardioComm Solutions and Vigilance Form Joint Venture 12
CardioComm Solutions Enters Into Co-Development Agreement With Monebo Technologies For ECG Interpretation Software 13
CardioComm Solutions Enters Into Technology Integration Agreement With Royal Philips Electronics 15
CardioComm Solutions Enters Into Technology Integration Agreement With TZ Medical 16
CardioComm Solutions Enters Into Distribution Agreement With TZ Medical 17
CardioComm Solutions Completes First Tranche Of Private Placement For US$0.1 Millon 18
CardioComm Solutions Completes Private Placement Of Units For US$0.12 Million 19
CardioComm Solutions Completes Private Placement Of Units For US$1.55 Million 20
CardioComm Solutions Completes Private Placement Of Common Stock For US$1 Million Upon Exercise Of Warrants 22
CardioComm Solutions Inc, Key Competitors 23
CardioComm Solutions Inc, Key Employees 24
CardioComm Solutions Inc, Other Locations 25
CardioComm Solutions Inc, Subsidiaries 25

List of Figures
CardioComm Solutions Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
CardioComm Solutions Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
CardioComm Solutions Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
CardioComm Solutions Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
CardioComm Solutions Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
CardioComm Solutions Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
CardioComm Solutions Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
CardioComm Solutions Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[CardioComm Solutions Inc (EKG):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Grupa Azoty Zaklady Chemiczne Police SA (PCE):企業の財務・戦略的SWOT分析
    Grupa Azoty Zaklady Chemiczne Police SA (PCE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • ImmunoCellular Therapeutics Ltd (IMUC):製薬・医療:M&Aディール及び事業提携情報
    Summary ImmunoCellular Therapeutics Ltd (IMCU) is a clinical-stage biotechnology company which develops immune-based therapies for the treatment of various cancers. The product pipeline of the company includes active immunotherapies and patented monoclonal antibodies. IMCU’s immunotherapies product …
  • Raschig GmbH:企業の戦略的SWOT分析
    Raschig GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Vietnam National Petroleum Group (PLX):企業の財務・戦略的SWOT分析
    Vietnam National Petroleum Group (PLX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Thermalin Diabetes LLC-製薬・医療分野:企業M&A・提携分析
    Summary Thermalin Diabetes LLC (Thermalin) is an insulin analogs developer. The company develops concentrated insulin analog for the treatment of individuals with insulin resistance and for use in miniature insulin pumps. It develops both molecular and formulation strategies to produce an acting ana …
  • TiVo Corp.:企業の戦略・SWOT・財務分析
    TiVo Corp. - Strategy, SWOT and Corporate Finance Report Summary TiVo Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • The Dun & Bradstreet Corporation:企業の戦略・SWOT・財務分析
    The Dun & Bradstreet Corporation - Strategy, SWOT and Corporate Finance Report Summary The Dun & Bradstreet Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • AcuFocus Inc:医療機器:M&Aディール及び事業提携情報
    Summary AcuFocus Inc (AcuFocus) is an ophthalmic medical device company that develops and markets technologies for the improvement of near vision. The company develops and markets breakthrough technologies for the improvement of vision. It’s IC-8 IOL, a small aperture lens that is designed for preby …
  • Alamo Group, Inc.:戦略・SWOT・企業財務分析
    Alamo Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Alamo Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Petoro AS:企業の戦略的SWOT分析
    Petoro AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • Elizabeth Arden, Inc. (RDEN):企業の財務・戦略的SWOT分析
    Elizabeth Arden, Inc. (RDEN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • AS Kevelt-製薬・医療分野:企業M&A・提携分析
    Summary AS Kevelt (Kevelt), a subsidiary of Pharmsynthez is a healthcare company that develops, manufactures and markets drug products. The company offers products which include concentrate solutions for infusion, endocervical gel, eye drops and other solutions. It also offers sub-contracting and di …
  • ACB Securities Co Ltd:企業の戦略的SWOT分析
    ACB Securities Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Laboratorios Liomont SA de CV:製薬・医療:M&Aディール及び事業提携情報
    Summary Laboratorios Liomont SA de CV (Liomont) is a pharmaceutical company that develops medication products. The company offers prescription medication products, biotech products and over the counter products. It provides drugs in various therapeutic areas including analgesics, antiparasitic, anti …
  • Grupa Azoty SA (ATT):企業の財務・戦略的SWOT分析
    Grupa Azoty SA (ATT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Idacorp Inc (IDA):企業の財務・戦略的SWOT分析
    Summary Idacorp Inc (Idacorp) is an electric utility that distributes, markets, generates and purchases electricity. The utility owns natural gas-fired power plants and in coal-fired generating stations. It offers real estate investments and housing projects. Idacorp owns three coal-fired generating …
  • 3I Group Plc:企業の戦略・SWOT・財務分析
    3I Group Plc - Strategy, SWOT and Corporate Finance Report Summary 3I Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • BioMarin Pharmaceutical Inc (BMRN):製薬・医療:M&Aディール及び事業提携情報
    Summary BioMarin Pharmaceutical Inc (BioMarin) is a biopharmaceutical company which develops and commercializes innovative pharmaceuticals for treatment of serious diseases and medical conditions, such as Kyndrisa (drisapersen), Duchenne muscular dystrophy (DMD), phenylketonuria (PKU), achondroplasi …
  • Rohol-Aufsuchungs Aktiengesellschaft:石油・ガス:M&Aディール及び事業提携情報
    Summary Rohol-Aufsuchungs Aktiengesellschaft (RAG) is an oil and gas company. The company operates in oil and gas exploration, production and trading; and gas storage. It produces crude oil and natural gas. RAG offers services such as renewable energy projects development and crude oil stockpiling a …
  • Peregrine Holdings Ltd:企業の戦略・SWOT・財務分析
    Peregrine Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Peregrine Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆